Alstrom Syndrome: A Systematic Review

Alstrom syndrome (AS) is a rare multisystem disorder characterized by cone-rod retinal dystrophy leading to vision loss, hearing deficiency, obesity, type 2 diabetes mellitus, and insulin resistance with hyperinsulinemia. The conditions include dilated cardiomyopathy, recurrent fibrotic pulmonary infections, and progressive renal, hepatic, and endocrinological dysfunction. Other clinical findings consist of thyroid problems, short height, and growth hormone insufficiency. In addition, patients present with normal IQ, but in some cases delay in psychomotor and cognitive development is described. There is no treatment for AS, and life expectancy is around 40 years. However, an early identification of the disease can help in reducing the progression to severe conditions and in ameliorating the patient's quality of life. Our intent was to analyze the clinical data in literature on AS and provide an up-to-date review.

Automated summary

Alstrom syndrome is a rare multisystem disorder characterized by vision loss, hearing deficiency, obesity, type 2 diabetes mellitus, and insulin resistance. It can also lead to cardiac, pulmonary, renal, hepatic, and endocrinological dysfunctions. Early identification of the disease can help slow down its progression and improve the patient's quality of life.